HTA Database - Search Results

Sort by Relevance

Search Results [15923 Hits] Selected Records [0 Hits] [Clear]

Year	Source	Title
2013	NIHR Health Technology Assessment programme	The impact of continuous haemofiltration with high-volume fluid exchange during cardiopulmonary bypass surgery on the recovery of patients with impaired renal function: a pilot randomised trial
2013	NIHR Health Technology Assessment programme	Dabigatran for the prevention of stroke and systemic embolism in atrial fibrillation: A NICE single technology appraisal
2013	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of technology appraisal No. 150 and part review of technology appraisal No. 118): a systematic review and economic model
2013	NIHR Health Technology Assessment programme	Randomised Assessment of Treatment using Panel Assay of Cardiac markers - Contemporary Biomarker Evaluation (RATPAC CBE)
2013	NIHR Health Technology Assessment programme	The effectiveness and cost-effectiveness of acupressure for the control and management of chemotherapy-related acute and delayed nausea: Assessment of Nausea in Chemotherapy Research (ANCHoR), a randomised controlled trial
2013	NIHR Health Technology Assessment programme	Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: systematic review and economic model
2013	NIHR Health Technology Assessment programme	Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis
2013	NIHR Health Technology Assessment programme	Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome
2013	The Swedish Council on Health Technology Assessment (SBU)	[Transient elastography in fibrosis staging]
2013	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Newborn screening for cystic fibrosis. Efficacy/ effectiveness and implementation protocols]
2013	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Transapical and transfemoral aortic valve implantation: proposal of indicators for post-introduction observation]
2013	Agency for Healthcare Research and Quality (AHRQ)	Epoetin and darbepoetin for managing anemia in patients undergoing cancer treatment: comparative effectiveness update
2013	Agency for Healthcare Research and Quality (AHRQ)	Childhood obesity prevention programs: comparative effectiveness review and meta-analysis
2013	NIHR Health Technology Assessment programme	Lithium or an atypical antipsychotic drug in the management of treatment resistant depression: a systematic review and economic evaluation
2013	NIHR Health Technology Assessment programme	A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression
2013	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation
2013	NIHR Health Technology Assessment programme	A systematic review and economic evaluation of new-generation computed tomography scanners for imaging in coronary artery disease and congenital heart disease: Somatom Definition Flash, Aquilion ONE, Brilliance iCT and Discovery CT750 HD
2013	NIHR Health Technology Assessment programme	Clinical effectiveness of first-line chemoradiation for adult patients with locally advanced non-small cell lung cancer: a systematic review
2013	Agency for Healthcare Research and Quality (AHRQ)	Stroke prevention in atrial fibrillation
2013	Agency for Healthcare Research and Quality (AHRQ)	Comparative effectiveness of psychological treatments and pharmacological treatments for adults with posttraumatic stress disorder (PTSD)
2013	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Medical specialist attendance in nursing homes]
2013	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Prevention of fetal alcohol syndrome]
2013	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Efficacy and efficiency of psychological, psychiatric, sociomedical and complementary medical interventions for excessive crying in primary care services ("Schreiambulanzen") ]
2013	NIHR Health Technology Assessment programme	A systematic review and cost-effectiveness analysis of specialist services and adrenaline auto-injectors in anaphylaxis
2013	NIHR Health Technology Assessment programme	Adjunctive colposcopy technologies for examination of the uterine cervix - DySIS, LuViva Advanced Cervical Scan and Niris Imaging System: a systematic review and economic evaluation
2013	NIHR Health Technology Assessment programme	Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis
2013	NIHR Health Technology Assessment programme	Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation
2013	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Overweight and obesity: the efficacy of diets for weight maintenance after weight loss]
2013	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[The effectiveness of occupational therapy for persons with moderate and severe dementia]
2013	NIHR Health Technology Assessment programme	Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project
2013	NIHR Health Technology Assessment programme	SeHCAT (Tauroselcholic [75 selenium] acid) for the investigation of bile acid malabsorption (BAM) and measurement of bile acid pool loss
2013	NIHR Health Technology Assessment programme	Screening for type 2 diabetes: a short report for the National Screening Committee
2013	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of depth of anaesthesia monitoring (E-Entropy, Bispectral Index and Narcotrend): a systematic review and economic evaluation
2013	NIHR Health Technology Assessment programme	Rapid fetal fibronectin (fFN) testing to predict pre-term birth in women with symptoms of premature labour: A systematic review and cost-effectiveness analysis
2013	NIHR Health Technology Assessment programme	Pirfenidone for the treatment of idiopathic pulmonary fibrosis
2013	NIHR Health Technology Assessment programme	Ivabradine for the treatment of chronic heart failure
2013	NIHR Health Technology Assessment programme	Fluocinolone acetonide intravitreal implant for the treatment of chronic diabetic macular oedema
2013	Health Information and Quality Authority (HIQA)	Health technology assessment (HTA) of surveillance of women aged less than 50 years at elevated risk of breast cancer
2013	Adelaide Health Technology Assessment (AHTA)	Australian guidelines for the treatment of acute stress disorder and posttraumatic stress disorder
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Assessment of the PARLER (Programme d'Accès Rapide Lavallois en Rhumatologie) program]
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[The efficacy of rehabilitative interventions and pharmacological treatments for children aged 2 to 12 years with autism spectrum disorder (ASD)]
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Advisability of expanding the Québec newborn blood screening program]
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Use of medullary neurostimulators for the treatment of chronic non-cancer pain]
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Abraxane in combination with gemcitabine for metastatic pancreatic cancer – first line
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Bevacizumab (Avastin) for relapsed platinum-resistant ovarian cancer – second line
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Erismodegib for locally advanced or metastatic basal cell carcinoma
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Erlotinib (Tarceva) for the adjuvant treatment of EGFR positive non-small cell lung cancer
2013	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Renal sympathetic denervation as treatment of resistant hypertension]
2013	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Canaloplasty for open angle glaucoma]
2013	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) for corneal endothelial dysfunction]
2013	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Neonatal screening of sickle cell anemia]
2013	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Automated reading methods of uterine cervical cytology]
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Trebananib in combination with chemotherapy for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Tertomotide for locally advanced or metastatic pancreatic cancer
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Ospemifene for vulvo-vaginal atrophy in postmenopausal women
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Avatrombopag for immune (idiopathic) thrombocytopenic purpura
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Preladenant for Parkinson's disease – monotherapy or adjunct to levodopa therapy
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Dexamethasone intraocular injection (Verisome) for prevention and treatment of post-ocular surgery inflammation
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Intravitreal sirolimus (Opsiria) for chronic non-infectious posterior segment uveitis – first or second line
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Lesinurad for gout
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Apremilast for psoriasis
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Apremilast for psoriatic arthritis
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Phagenyx™ for stroke-induced dysphagia
2013	NIHR Health Technology Assessment programme	Pragmatic cluster randomised trial of PhysioDirect telephone assessment and advice services for physiotherapy
2013	The Regional Health Technology Assessment Centre (HTA-centrum)	Renal sympathetic denervation in patients with therapy resistant hypertension
2013	Health Technology and Policy Unit (HTPU)	Level I and level III sleep studies for the diagnosis of sleep disordered breathing (SDB) in adults
2013	Agency for Healthcare Research and Quality (AHRQ)	Assessment and management of chronic cough
2013	Agency for Healthcare Research and Quality (AHRQ)	Outpatient case management for adults with medical illness and complex care needs
2013	Agency for Healthcare Research and Quality (AHRQ)	Child and adolescent exposure to trauma: comparative effectiveness of interventions addressing trauma other than maltreatment or family violence
2013	Agency for Healthcare Research and Quality (AHRQ)	Intravascular diagnostic procedures and imaging techniques versus angiography alone in coronary artery stenting: comparative effectiveness review
2013	Agency for Healthcare Research and Quality (AHRQ)	Insulin delivery and glucose monitoring methods: future research needs
2013	Agency for Healthcare Research and Quality (AHRQ)	Efficacy and safety of screening for postpartum depression
2013	Agency for Healthcare Research and Quality (AHRQ)	Technology assessment on genetic testing or molecular pathology testing of cancers with unknown primary site to determine origin
2013	Agency for Healthcare Research and Quality (AHRQ)	Fluorescence In Situ Hybridization (FISH) or Other In Situ Hybridization (ISH) testing of uterine cervical cells to predict precancer and cancer
2013	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Colorectal-cancer-screening update; status in Austria and European countries; and quality assurance of screening-colonoscopy]
2013	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Marketing authorisations under exceptional circumstances for oncology drugs: an analysis of approval and reimbursement decisions of four drugs
2013	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Crizotinib (Xalkori®) for the treatment of anaplastic lymphoma kinase (ALK) positive advanced non-small cell lung cancer (NSCLC)
2013	HAYES, Inc.	Continuous passive motion for the treatment of joint contractures of the extremities
2013	HAYES, Inc.	Epidural steroid injections for low back pain and sciatica
2013	HAYES, Inc.	Laparoscopic CO2 laser ablation for endometriosis
2013	HAYES, Inc.	Magnetic resonance elastography for detecting and staging liver fibrosis
2013	HAYES, Inc.	Mechanical stretching devices for the treatment of joint contractures of the extremities
2013	HAYES, Inc.	Percutaneous left atrial appendage closure to reduce stroke risk in patients with atrial fibrillation
2013	HAYES, Inc.	Positron Emission Tomography (PET) and Combined Positron Emission Tomography-Computed Tomography (PET-CT) for the posttreatment management of cancer of the head and neck
2013	HAYES, Inc.	Serological assays for the diagnosis and management of inflammatory bowel disease: crohn's disease
2013	HAYES, Inc.	Simultaneous pancreas-kidney (SPK) transplantation in diabetic patients
2013	HAYES, Inc.	Testosterone for low sexual desire in nonsurgically postmenopausal women
2013	HAYES, Inc.	Transradial, transbrachial, and transulnar approaches for coronary angiography and intervention
2013	HAYES, Inc.	BRAF p.Val600Glu testing in papillary thyroid carcinoma
2013	HAYES, Inc.	Ehlers-danlos syndrome (EDS), classic type
2013	HAYES, Inc.	Familial mediterranean fever (FMF)
2013	HAYES, Inc.	Interleukin 28B (IL28B) testing to predict response to treatment of hepatitis C virus (HCV) infection
2013	HAYES, Inc.	Kabuki syndrome
2013	HAYES, Inc.	PreOvar KRAS-variant test for ovarian cancer
2013	HAYES, Inc.	C-leg prostheses (Otto Bock HealthCare LP) for patients with above-knee amputation
2013	HAYES, Inc.	Coflex interlaminar stabilization device (Paradigm Spine LLC) for treatment of lumbar spinal stenosis
2013	HAYES, Inc.	CyberKnife robotic radiosurgery system (Accuray Inc.) for treatment of prostate cancer
2013	HAYES, Inc.	Impella recover LP 2.5 percutaneous cardiac support system (Abiomed Inc.) for patients undergoing high-risk percutaneous coronary intervention (PCI)
2013	HAYES, Inc.	iStent trabecular micro-bypass stent (Glaukos Corp.) for treatment of primary open-angle glaucoma
2013	HAYES, Inc.	MindStreams cognitive health assessment (NeuroTrax Corp.) product suite (U.S. Clinical Edition) for assessing mild cognitive impairment